Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells

Stem Cell Research and Therapy

Volumn 4, Issue 2, 2013, Pages

  Patrikoski, Mimmi ^a,b,c   Juntunen, Miia ^a,b,c   Boucher, Shayne ^d   Campbell, Andrew ^e   Vemuri, Mohan C ^d   Mannerström, Bettina ^a,b,c   Miettinen, Susanna ^a,b,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d Life Technologies Inc   (United States)

^e Life Technologies   (United States)

Author keywords

Adipose stem cells; Cell therapy; Fetal bovine serum; Flow cytometry; Human serum; Immunophenotype; Multipotentiality; Proliferation rate; Serum free; Xeno free

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; B7 ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD45RO ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; ENDOGLIN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THY 1 ANTIGEN; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR RUNX2; CULTURE MEDIUM; LEUKOCYTE ANTIGEN;

ADIPOSE DERIVED STEM CELL; ADULT; ALKALINE PHOSPHATASE GENE; AP2 GENE; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CULTURE AND TRANSPORT MEDIA; CULTURE MEDIUM; DLX5 GENE; DNA SEQUENCE; DOWN REGULATION; FEMALE; FETAL CALF SERUM; GENE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOPHENOTYPING; MATERIAL COATING; NUCLEOTIDE SEQUENCE; PPAR GAMMA GENE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN EXPRESSION; RUNX2 GENE; SERUM; STEM CELL TRANSPLANTATION; XENO FREE CULTURE MEDIUM; ADIPOSE TISSUE; BIOLOGICAL THERAPY; BONE DEVELOPMENT; CELL CULTURE; CHONDROGENESIS; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; MIDDLE AGED; PHARMACOLOGY; PROCEDURES; STEM CELL;

ANIMALIA; BOVINAE;

ADIPOSE TISSUE; ADULT; ANTIGENS, CD; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; CHONDROGENESIS; CULTURE MEDIA, SERUM-FREE; FEMALE; HUMANS; IMMUNOPHENOTYPING; MIDDLE AGED; OSTEOGENESIS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84876100878     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt175     Document Type: Article

References (43)

1. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Gimble J, Guilak F, Cytotherapy 2003 5 362 369 10.1080/14653240310003026 14578098 (Pubitemid 37369023)
2. Human adipose tissue is a source of multipotent stem cells. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH, Mol Biol Cell 2002 13 4279 4295 10.1091/mbc.E02-02-0105 12475952 (Pubitemid 35471185)
3. Multilineage cells from human adipose tissue: implications for cell-based therapies. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH, Tissue Eng 2001 7 211 228 10.1089/107632701300062859 11304456 (Pubitemid 32295155)
4. Cranioplasty with adipose-derived stem cells and biomaterial: a novel method for cranial reconstruction. Thesleff T, Lehtimaki K, Niskakangas T, Mannerstrom B, Miettinen S, Suuronen R, Ohman J, Neurosurgery 2011 68 1535 1540 10.1227/NEU.0b013e31820ee24e 21336223
5. Adipose-derived stromal cells: their identity and uses in clinical trials: an update. Casteilla L, Planat-Benard V, Laharrague P, Cousin B, World J Stem Cells 2011 3 25 33 10.4252/wjsc.v3.i4.25 21607134
6. Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials. Mizuno H, Curr Opin Mol Ther 2010 12 442 449 20677095
7. Minimal criteria for defining multipotent mesenchymal stromal cells: The International Society for Cellular Therapy position statement. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E, Cytotherapy 2006 8 315 317 10.1080/14653240600855905 16923606 (Pubitemid 44269669)
8. Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice. Niemeyer P, Vohrer J, Schmal H, Kasten P, Fellenberg J, Suedkamp NP, Mehlhorn AT, Cytotherapy 2008 10 784 795 10.1080/14653240802419302 18951271
9. Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model. Kuo YR, Chen CC, Goto S, Lee IT, Huang CW, Tsai CC, Wang CT, Chen CL, Plast Reconstr Surg 2011 128 661e 672e 10.1097/PRS.0b013e318230c60b 22094768
10. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, Taureau C, Cousin B, Abbal M, Laharrague P, Penicaud L, Casteilla L, Blancher A, Br J Haematol 2005 129 118 129 10.1111/j.1365-2141.2005.05409.x 15801964 (Pubitemid 40524060)
11. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Niemeyer P, Kornacker M, Mehlhorn A, Seckinger A, Vohrer J, Schmal H, Kasten P, Eckstein V, Sudkamp NP, Krause U, Tissue Eng 2007 13 111 121 10.1089/ten.2006.0114 17518585 (Pubitemid 46175533)
12. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Mackensen A, Drager R, Schlesier M, Mertelsmann R, Lindemann A, Cancer Immunol Immunother 2000 49 152 156 10.1007/s002620050614 10881694 (Pubitemid 30430064)
13. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Selvaggi TA, Walker RE, Fleisher TA, Blood 1997 89 776 779 9028307 (Pubitemid 27121269)
14. Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: potential feasibility for clinical applications. Tateishi K, Ando W, Higuchi C, Hart DA, Hashimoto J, Nakata K, Yoshikawa H, Nakamura N, Cell Transplant 2008 17 549 557 10.3727/ 096368908785096024 18714674
15. Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures. Schallmoser K, Strunk D, J Vis Exp 2009 10.3791/1523
16. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D, Kluter H, Stem Cells 2009 27 2331 2341 10.1002/stem.139 19544413
17. Low serum and serum-free culture of multipotential human adipose stem cells. Parker AM, Shang H, Khurgel M, Katz AJ, Cytotherapy 2007 9 637 646 10.1080/14653240701508452 17917877 (Pubitemid 47604653)
18. Calcium phosphate surface treatment of bioactive glass causes a delay in early osteogenic differentiation of adipose stem cells. Haimi S, Moimas L, Pirhonen E, Lindroos B, Huhtala H, Raty S, Kuokkanen H, Sandor GK, Miettinen S, Suuronen R, J Biomed Mater Res A 2009 91 540 547 18985777
19. Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro. Lindroos B, Boucher S, Chase L, Kuokkanen H, Huhtala H, Haataja R, Vemuri M, Suuronen R, Miettinen S, Cytotherapy 2009 11 958 972 10.3109/14653240903233081 19903107
20. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC, Proc Natl Acad Sci U S A 1998 95 10614 10619 10.1073/pnas.95.18. 10614 9724752 (Pubitemid 28413116)
21. Growth and osteogenic differentiation of adipose stem cells on PLA/bioactive glass and PLA/beta-TCP scaffolds. Haimi S, Suuriniemi N, Haaparanta AM, Ella V, Lindroos B, Huhtala H, Raty S, Kuokkanen H, Sandor GK, Kellomaki M, Miettinen S, Suuronen R, Tissue Eng Part A 2009 15 1473 1480 10.1089/ten.tea.2008.0241 19072198
22. Formation of cartilage-like spheroids by micromass cultures of murine C3H10T1/2 cells upon treatment with transforming growth factor-beta 1. Denker AE, Nicoll SB, Tuan RS, Differentiation 1995 59 25 34 10.1046/j.1432-0436.1995. 5910025.x 7589892
23. Use of adipose stem cells and polylactide discs for tissue engineering of the temporomandibular joint disc. Maenpaa K, Ella V, Mauno J, Kellomaki M, Suuronen R, Ylikomi T, Miettinen S, J R Soc Interface 2010 7 177 188 10.1098/rsif.2009.0117 19474082
24. A new mathematical model for relative quantification in real-time RT-PCR. Pfaffl MW, Nucleic Acids Res 2001 29 45 10.1093/nar/29.9.e45 11328886
25. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, Lynch PJ, Hsu SC, Smith J, Prockop DJ, Mol Ther 2004 9 747 756 10.1016/j.ymthe.2004.02.012 15120336 (Pubitemid 38660428)
26. Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Trivedi HL, Vanikar AV, Thakker U, Firoze A, Dave SD, Patel CN, Patel JV, Bhargava AB, Shankar V, Transplant Proc 2008 40 1135 1139 10.1016/j.transproceed.2008.03.113 18555133 (Pubitemid 351802232)
27. Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal. Tzouvelekis A, Koliakos G, Ntolios P, Baira I, Bouros E, Oikonomou A, Zissimopoulos A, Kolios G, Kakagia D, Paspaliaris V, Kotsianidis I, Froudarakis M, Bouros D, J Transl Med 2011 9 182 10.1186/1479-5876-9-182 22017817
28. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Mesimaki K, Lindroos B, Tornwall J, Mauno J, Lindqvist C, Kontio R, Miettinen S, Suuronen R, Int J Oral Maxillofac Surg 2009 38 201 209 10.1016/j.ijom.2009.01.001 19168327
29. Human adipose derived stroma/stem cells grow in serum-free medium as floating spheres. Dromard C, Bourin P, Andre M, De Barros S, Casteilla L, Planat-Benard V, Exp Cell Res 2011 317 770 780 10.1016/j.yexcr.2011.01.001 21255567
30. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions. Santos F, Andrade PZ, Abecasis MM, Gimble JM, Chase LG, Campbell AM, Boucher S, Vemuri MC, Silva CL, Cabral JM, Tissue Eng Part C Methods 2011 17 1201 1210 21895491
31. Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications. Naaijkens BA, Niessen HW, Prins HJ, Krijnen PA, Kokhuis TJ, de Jong N, van Hinsbergh VW, Kamp O, Helder MN, Musters RJ, van Dijk A, Juffermans LJ, Cell Tissue Res 2012 348 119 130 10.1007/s00441-012-1360-5 22395775
32. Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Blande IS, Bassaneze V, Lavini-Ramos C, Fae KC, Kalil J, Miyakawa AA, Schettert IT, Krieger JE, Transfusion 2009 49 2680 2685 10.1111/j.1537-2995.2009.02346.x 19694997
33. A novel serum-free medium for the expansion of human mesenchymal stem cells. Chase LG, Lakshmipathy U, Solchaga LA, Rao MS, Vemuri MC, Stem Cell Res Ther 2010 1 8 10.1186/scrt8 20504289
34. Defined xenogeneic-free and hypoxic environment provides superior conditions for long-term expansion of human adipose-derived stem cells. Yang S, Pilgaard L, Chase L, Boucher S, Vemuri M, Fink TD, Zachar V, Tissue Eng Part C Methods 2012 18 593 602 10.1089/ten.tec.2011.0592 22364177
35. Efficiently differentiating vascular endothelial cells from adipose tissue-derived mesenchymal stem cells in serum-free culture. Konno M, Hamazaki TS, Fukuda S, Tokuhara M, Uchiyama H, Okazawa H, Okochi H, Asashima M, Biochem Biophys Res Commun 2010 400 461 465 10.1016/j.bbrc.2010.08.029 20708604
36. Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues. Mirabet V, Solves P, Minana MD, Encabo A, Carbonell-Uberos F, Blanquer A, Roig R, Cell Tissue Bank 2008 9 1 10 10.1007/s10561-007-9048-x 17578684 (Pubitemid 351279795)
37. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Rebelatto CK, Aguiar AM, Moretao MP, Senegaglia AC, Hansen P, Barchiki F, Oliveira J, Martins J, Kuligovski C, Mansur F, Christofis A, Amaral VF, Brofman PS, Goldenberg S, Nakao LS, Correa A, Exp Biol Med (Maywood) 2008 233 901 913 10.3181/0712-RM-356
38. The correlation between human adipose-derived stem cells differentiation and cell adhesion mechanism. Park IS, Han M, Rhie JW, Kim SH, Jung Y, Kim IH, Kim SH, Biomaterials 2009 30 6835 6843 10.1016/j.biomaterials.2009.08.057 19781767
39. Adhesion and differentiation of adipose-derived stem cells on a substrate with immobilized fibroblast growth factor. Kang JM, Han M, Park IS, Jung Y, Kim SH, Kim SH, Acta Biomater 2012 8 1759 1767 10.1016/j.actbio.2012.01.005 22285427
40. Consistent osteoblastic differentiation of human mesenchymal stem cells with bone morphogenetic protein 4 and low serum. Cordonnier T, Langonne A, Sohier J, Layrolle P, Rosset P, Sensebe L, Deschaseaux F, Tissue Eng Part C Methods 2011 17 249 259 20822481
41. The effect of bioactive glasses on bone marrow stromal cells differentiation. Bosetti M, Cannas M, Biomaterials 2005 26 3873 3879 10.1016/j.biomaterials.2004.09.059 15626435 (Pubitemid 40038778)
42. Beta-tricalcium phosphate 3D scaffold promote alone osteogenic differentiation of human adipose stem cells: in vitro study. Marino G, Rosso F, Cafiero G, Tortora C, Moraci M, Barbarisi M, Barbarisi A, J Mater Sci Mater Med 2010 21 353 363 10.1007/s10856-009-3840-z 19655233
43. Multifunctional hybrid three-dimensionally woven scaffolds for cartilage tissue engineering. Moutos FT, Estes BT, Guilak F, Macromol Biosci 2010 10 1355 1364 10.1002/mabi.201000124 20857388